Erlotinib and fatigue 
Erlotinib and fatigue Patient Reports February 11, 2012
Erlotinib Side Effects Report #5500207-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 10, 2007. Female patient, weighting 124.0 lb, was diagnosed with tongue cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, fatigue, pain
, pneumonia aspiration. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6025814-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Male patient, 66 years of age, weighting 194.0 lb, was diagnosed with renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, hypotension, renal failure. Erlotinib dosage: (50 MG,QD),ORAL. During the same period patient was treated with SUNITINIB MALATE, LIPITOR, LISINOPRIL, MINOCYCLINE, NIACIN, PANTOPRAZOLE, POTASSIUM CHLORIDE, ALEVE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5455928-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 30, 2007. Female patient was diagnosed with pulmonary mass and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, clavicle fracture, disease progression, fall
, fatigue, pain . Erlotinib dosage: 150 MG (QD, ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LEVAQUIN, POTASSIUM CHLORIDE, NEULASTA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5420772-7
Erlotinib side effect was reported by a Physician from CANADA on Aug 01, 2007. Female patient, 69 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, clostridial infection, decreased appetite, failure to thrive, fatigue, haemoglobin decreased, oral intake reduced. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, BEVACIZUMAB, CRESTOR, GLYBURIDE, METFORMIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5230798-4
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 17, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: depressed mood, fatigue, left ventricular failure, pleural effusion, vomiting. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, OMEPRAZOLE, LOPERAMIDE, METOCLOPRAMIDE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5877487-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 25, 2008. Male patient, 72 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anorexia, asthenia, atrial flutter, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, sinus tachycardia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, BACTRIM, ALBUTEROL, ESOMEPRAZOLE MAGNESIUM. Patient recovered.
Erlotinib Side Effects Report #5783016-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2008. Male patient, weighting 138.9 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, disease progression, dysphagia, fatigue, nausea
, odynophagia, oral intake reduced, weight decreased. Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with BEVACIZUMAB, PROGRAF, MYFORTIC, PREVACID, LIPITOR, PREDNISONE, METOPROLOL SUCCINATE, ASPIRIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5710611-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Female patient, 75 years of age, weighting 151.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anaemia, diarrhoea, diverticulum, dyspnoea, fatigue, gallbladder disorder, haematocrit decreased, haemoglobin decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, NORVASC, BENAZEPRIL, LEXAPRO, DETROL, CLARINEX, HYDROCHLOROTHIAZIDE, IRON POLYSACCHARIDE. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5235111-4
Erlotinib side effect was reported by a Physician from POLAND on Jan 23, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, diarrhoea, fatigue. Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5374082-7
Erlotinib side effect was reported by a Physician from UNITED STATES on June 12, 2007. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, fatigue, hydropneumothorax, hypoxia, lung neoplasm, mucosal exfoliation, mucosal inflammation, oesophageal stenosis. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with MUPIROCIN CREAM, NORVASC, ENALAPRIL, SYNTHROID, SYSTANE, BENZOCAINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5192470-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 04, 2006. Male patient, 63 years of age, weighting 174.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: decreased appetite, fatigue. Erlotinib dosage: 1500 MG (QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ADVAIR, SPIRIVA, BENICAR, PREVPAC, CARAFATE, NYSTATIN. Patient died.
Erlotinib Side Effects Report #5930424-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2008. Male patient, 62 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, dehydration, diarrhoea, fatigue, hyperuricaemia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with VALIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULPHATE, PERCOCET, PROCHLORPERAZINE MALEATE, PREDNISONE, BENAZEPRIL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5956177-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 30, 2008. Male patient, 62 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, dehydration, diarrhoea, fatigue, hyperuricaemia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with VALIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULPHATE, PERCOCET, PROCHLORPERAZINE MALEATE, PREDNISONE, BENAZEPRIL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5798945-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 59 years of age, weighting 166.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain
, cough, fatigue, hyperhidrosis, nephritis interstitial, pyrexia, renal failure, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOPROLOL TARTRATE, LOPERAMIDE HYDROCHLORIDE, PAREGORIC, ACETAMINOPHEN, VITAMIN B6, IRON. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6060255-7
Erlotinib side effect was reported by a Physician from POLAND on Jan 15, 2009. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fatigue, hypomagnesaemia, lung neoplasm malignant, malignant neoplasm progression, nausea
. Erlotinib dosage: unknown. During the same period patient was treated with AMARYL, MAGNESIUM, TRAMADOL, KETOPROFEN, OMEPRAZOLE, TORECAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6125212-0
Erlotinib side effect was reported by a Health Professional from UKRAINE on Mar 03, 2009. Male patient, 59 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain
, coma, cough, dizziness , fatigue, gait disturbance, hypotension, malignant neoplasm progression, metastases to central nervous system. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LOPERAMIDE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5670021-X
Erlotinib side effect was reported by a Health Professional from HUNGARY on Feb 27, 2008. Male patient, 49 years of age, weighting 249.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, dermatitis acneiform, fatigue, febrile neutropenia, headache , pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PEMETREXED, TIOTROPIUM BROMIDE, FOLIC ACID, VITAMIN B12, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6137759-1
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 11, 2009. Male patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature decreased, dehydration, diarrhoea, fatigue, hypomagnesaemia, rash
, renal failure acute, renal impairment, thirst. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5174252-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 20, 2006. Female patient, 70 years of age, weighting 145.9 lb, was diagnosed with neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, cough, fatigue, febrile neutropenia, haematocrit decreased, platelet count decreased, vomiting. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, SENOKOT, ATIVAN, TYLENOL, LEVAQUIN, MUCINEX, GUAIFENESIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5567677-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Male patient, 80 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, fatigue, nausea
. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5832823-6
Erlotinib side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on July 17, 2008. Female patient, 68 years of age, weighting 97.00 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aspartate aminotransferase increased, diarrhoea, fatigue, hypoalbuminaemia, laboratory test abnormal, pulmonary embolism
, pulmonary infarction, thrombocytopenia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FUROSEMIDE, METOPROLOL TARTRATE, CALTRATE PLUS. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #6140788-5
Erlotinib side effect was reported by a Physician from GREECE on Mar 17, 2009. Male patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dizziness
, dysarthria, fatigue, metastases to central nervous system. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5875064-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 08, 2008. Female patient, 59 years of age, was diagnosed with lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, faeces discoloured, fatigue, gastrointestinal haemorrhage, hypoxia, lung disorder, pneumonia
. Erlotinib dosage: 150 MG ORAL ONCE DAILY. Patient died on 09/03/2008.Erlotinib Side Effects Report #5890310-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 05, 2008. Female patient, 59 years of age, was diagnosed with lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, gastrointestinal haemorrhage, hypoxia, pneumonia
. Erlotinib dosage: 150 MG,QD, ORAL. Patient was hospitalized. Patient died on 09/03/2008.Erlotinib Side Effects Report #5832824-8
Erlotinib side effect was reported by a Health Professional from JAPAN on July 18, 2008. Female patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, diarrhoea, disease progression, enterocolitis infectious, epilepsy
, fatigue. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ONEALFA, PHENYTOIN, THRYADIN. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5407965-X
Erlotinib side effect was reported by a Physician from UNITED STATES on July 20, 2007. Male patient, 67 years of age, weighting 159.2 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, dermatitis acneiform, fatigue, febrile neutropenia, limb discomfort, viral infection
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6022315-6
Erlotinib side effect was reported by a Physician from JAPAN on Dec 11, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, blood urea increased, dermatitis acneiform, diarrhoea, disease progression, dry skin, fatigue, hypochloraemia. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with OXYCONTIN, MORPHINE, RINDERON, BACTRAMIN, LOXONIN, MUCOSTA. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5607503-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2008. Male patient, 70 years of age, was diagnosed with colorectal cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood urea increased, condition aggravated, dehydration, fatigue, fistula , haematocrit decreased, hyperglycaemia, platelet count decreased. Erlotinib dosage: 75 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, EVEROLIMUS, NITROFURANTOIN, OXYCODONE, OXYCONTIN, CENTRUM, ENABLEX, DITROPAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5446954-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, fistula , hyperglycaemia, stress . Erlotinib dosage: 75 MG, QD. During the same period patient was treated with BEVACIZUMAB, EVEROLIMUS, DITROPAN, PRILOSEC, NORVASC. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5320144-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 18, 2007. Female patient, 75 years of age, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, clavicle fracture, condition aggravated, fall
, fatigue, pain . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LEVAQUIN, POTASSIUM, NEULASTA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5194441-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 06, 2006. Male patient, 45 years of age, weighting 175.5 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, asthenia, diarrhoea, fatigue, haemoglobin decreased, nausea , neutrophil count decreased, oedema, ureteric obstruction. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with ATENOLOL, ATIVAN, DECADRON, EMEND, INSULIN, LISINOPRIL, LOVENOX. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5019505-8
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2006. Female patient, weighting 200.6 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, fatigue, mucosal exfoliation, neutropenia, pyrexia, white blood cell count abnormal. Erlotinib dosage: 100 MG DAILY ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5027676-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2006. Female patient, weighting 200.6 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, abdominal pain upper, chest pain , diarrhoea, fatigue, mucosal exfoliation, nausea , neutropenia, pyrexia. Erlotinib dosage: 100 MG DAILY ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPITIN, AVASTIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5189804-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2006. Female patient, 51 years of age, weighting 215.0 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, asthenia, fatigue. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4744883-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 10, 2005. Male patient, 80 years of age, weighting 164.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium colitis, fatigue, haematocrit normal, nausea
, occult blood positive, orthostatic intolerance, weight decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GLEEVEC, LOVENOX, PHENOL, SIMETHICONE, QUININE SULPHATE, MORPHINE, PROMETHAZINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6051310-6
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 77 years of age, weighting 90.39 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, constipation
, diarrhoea, dyspnoea, exfoliative rash, fatigue, toothache, vomiting. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with SUNRYTHM, MUCOSTA, MUCOSOLVAN, SPIRIVA, TIZANIDINE, URSO, NEO MINOPHAGEN C, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5284210-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 72 years of age, weighting 151.5 lb, was diagnosed with salivary gland cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood sodium decreased, eye infection
, fatigue, nausea , oral discomfort, staphylococcal infection . Erlotinib dosage: 75 MG PO QD. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5196410-8
Erlotinib side effect was reported by a Physician from PHILIPPINES on Dec 11, 2006. Male patient, 71 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, fatigue, insomnia, neutrophil count increased, platelet count increased. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, TRAMADOL, METOCLOPRAMIDE, CO AMOXICLAV. Patient was hospitalized. Patient recovered.